#### Bluesight ControlCheck
Bluesight has published vendor-reported comparative outcomes and a press release asserting ControlCheck detected more diversion cases than other solutions in a vendor-reported analysis. Procurement teams should scrutinize methodology, comparator selection, and definitions of confirmed cases for vendor-published comparative analyses.
#### Omnicell
Omnicell positions analytics to detect diversion and has expanded its capabilities through a recent acquisition to strengthen diversion detection and case management. Omnicell may be attractive where ADC and medication management are already standardized on that vendor. Buyers should perform diligence on service levels and security hardening for specific deployments.
#### HelioMetrics
HelioMetrics offers a configurable analytics approach compatible with multiple ADC brands and customizable dashboards, which can appeal to organizations with internal capability to define workflows.
#### Where Sentri7 Drug Diversion differentiates
- Research lineage and published ML performance metrics from the Flowlytics/Invistics work provide an evidence-oriented background compared with vendors that present only marketing claims.
- Emphasis on multi-source reconciliation and integrated investigation workflows rather than alerting alone.